SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?


To: Steve who wrote (229)6/25/1998 11:08:00 PM
From: Dr. Bob  Read Replies (1) | Respond to of 496
 
I don't know, but my understanding is that the naturally-occurring endostatin is secreted by the primary tumor to suppress metastases. If the treatment drug is targeted similarly, it would probably be given intravenously, in order to get systemic effect, and because it is too large a molecule to be absorbed orally.

Bob